| Website | ablativesolutions... |
| Category | BioTech |
| Phone | (269) 352-4766 |
| info@ablativesolu... | |
| Employees | |
| Founded | 2011 |
| TOTAL | $5.3M |
| FUNDING TOTAL | $5.3M |
| Series A, 6/12 BioStar Ventures | $5.3M |
Ablative Solutions, Inc., was founded in 2011 by Tim Fischell, MD, FACC, and David Fischell, PhD, to address this significant unmet medical need. Ablative Solutions’ technology involves endovascular catheters to provide an efficacious, durable, cost-effective and safe alternative to surgical renal denervation for the treatment of hypertension and other diseases caused by an overactive sympathetic nervous system.
